Long-term outcome after sclerotherapy with or without a beta-blocker for variceal bleeding in children

Pediatrics International

Volumn 45, Issue 4, 2003, Pages 388-394

  Sökücü, Semra ^a   Süoǧlu, Özlem Durmaz ^b,c   Elkabes, Berna ^a   Saner, Günay ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Pediatric; Prophylaxis; Propranolol; Sclerotherapy; Variceal bleeding

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ARTICLE; BLEEDING; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; FATIGUE; FEMALE; HUMAN; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; TIME; TURKEY (REPUBLIC);

ANTIHYPERTENSIVE AGENTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; MALE; PROPRANOLOL; RECURRENCE; RETROSPECTIVE STUDIES; SCLEROTHERAPY; TIME FACTORS;

EID: 0141742716     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2003.01743.x     Document Type: Article

References (36)

1. Alvarez F, Bernard O, Brunelle F et al. Portal obstruction in children. 1. Clinical investigations and hemorrhage risk. J. Pediatr. 1983; 103: 703-7.
2. Fonkalsrud EW. Surgical management of portal hypertension in childhood. Arch. Surg. 1980; 115: 1043-5.
3. Warren WD, Millikan WJ, Smith RB et al. Non-cirrhotic portal venous thrombosis: Physiology before and after shunts. Ann. Surg. 1980; 192: 341-9.
4. Mitra SK, Rao KLN, Narasinham KL et al. Side to side lienorenal shunt without splenectomy in non-cirrhotic portal hypertension in children. J. Pediatr. Surg. 1993; 28: 398-402.
5. Prasad SA, Gupta S, Kohli V et al. Proximal splenorenal shunts for extrahepatic portal venous obstruction in children. Ann. Surg. 1994; 219: 193-6.
6. Shun A, Delaney DP, Martin HCO, Henry GM, Stephen M. Portosystemic shunting for pediatric portal hypertension. J. Pediatr. Surg. 1997; 32: 489-93.
7. Losty PD, Lynch MJ, Guiney EJ. Long-term outcome after surgery for extrahepatic portal vein thrombosis. Arch. Dis. Child. 1994; 71: 437-40.
8. Tomoaki K, Rene R, Raghad K et al. Portosystemic shunting in children during the era of endoscopic therapy: Improved postoperative growth parameters. J. Pediatr. Gastroenterol. Nutr. 2000; 30: 419-25.
9. Dilawari JB, Chawla YK, Ramesh GN, Mitra SK, Walia BNS. Endoscopic sclerotherapy in children. J. Gastroenterol. Hepatol. 1989; 4: 155-60.
10. Hill ID, Bowie MD. Endoscopic sclerotherapy for control of bleeding varices in children. Am. J. Gastroenterol. 1991; 86: 472-6.
11. Stringer MD, Howard ER. Long term outcome after injection sclerotherapy for oesophageal varices in children with extrahepatic portal venous obstruction. Gut 1994; 35: 257-9.
12. Yachha SK, Sharma BC, Kumar M, Khanduri A. Endoscopic sclerotherapy for oesophageal varices in children with extrahepatic portal venous obstruction: A follow-up study. J. Pediatr. Gastroenterol. Nutr. 1997; 24: 49-52.
13. Lebrec D, Poynard T, Bernuau J et al. A randomised controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A final report. Hepatology 1984; 4: 355-8.
14. Hayes PC, Dewis JM, Lewis JA, Bouchier IAD. Meta-analysis of value of propranolol in prevention of variceal hemorrhage. Lancet 1990; 336: 153-6.
15. Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Beta adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis. A meta-analysis. Hepatology 1997; 25: 63-70.
16. Özsoylu L, Koçak N, Demir H et al. Propranolol for primary and secondary prophylaxis of variceal bleeding in children with cirrhosis. Turk. J. Pediatr. 2000; 42: 31-3.
17. Burroughs AK, Jenkins WJ, Sherlock S et al. Controlled trial of propranolol for the prevention of recurrent variceal haemorrhage in patients with cirrhosis. N. Engl. J. Med. 1983; 309: 1539-42.
18. Villeneue JP, Pomier-Layrargues G, Infante-Rivard C et al. Propranolol for the prevention of recurrent variceal hemorrhage: A controlled trial. Hepatology 1986; 6: 1239-43.
19. Jensen LS, Krarup N. Propranolol may prevent recurrence of oesophageal varices after obliteration by endoscopic sclerotherapy. Scand. J. Gastroenterol. 1990; 25: 352-6.
20. O'Connor KW, Lehman G, Yune H et al. Comparison of three nonsurgical treatments for bleeding oesophageal varices. Gastroenterology 1989; 96: 899-906.
21. Howard ER, Swinger MD, Mowat AP. Assessment of injection sclerotherapy in management of 152 children with oesophageal varices. Br. J. Surg. 1988; 75: 404-8.
22. Feu F, Bordas JM, Luca A et al. Reduction of variceal pressure by propranolol: Comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis. Hepatology 1993; 18: 1082-9.
23. Shashidar H, Langhans N, Grand RJ. Propranolol in prevention of portal hypertensive hemorrhage in children: A pilot study. J. Pediatr. Gastroenterol. Nutr. 1999; 29: 12-17.
24. Thapa BR, Mehta S. Endoscopic sclerotherapy for oesophageal varices in infants and children. J. Pediatr. Gastroenterol. Nutr. 1990; 10: 430-34.
25. Paquet KJ. Ten years experience with paravariceal injection sclerotherapy of oesophageal varices in children. J. Pediatr. Surg. 1985; 20: 109-12.
26. Hassall E, Berquist WE, Ament ME et al. Sclerotherapy for extrahepatic portal hypertension in children. J. Pediatr. 1989; 115: 69-74.
27. Jensen LS, Krarup N. Propranolol in prevention of rebleeding from oesophageal varices during the course of endsocopic sclerotherapy. Scand. J. Gastroenterol. 1989; 24: 339-45.
28. Westaby D, MacDougall B, Williams R. Improved survival following injection sclerotherapy for oesophageal varices: Final analysis of a controlled trial. Hepatology 1985; 5: 827-30.
29. Terblanche J, Kahn D, Campbell JAH et al. Failure of repeated injection sclerotherapy to improve long term survival after oesophageal variceal bleeding. A five-year prospective controlled trial. Lancet 1983; ii: 1328-32.
30. Kahn D, Terblanche J, Kitane S, Bornman P. Injection sclerotherapy in adults with extrahepatic portal venous obstruction. Br. J. Surg. 1987: 74: 600-2.
31. Sarin SK, Sachdev G, Nanda R. Follow up of patients after variceal eradication. Ann. Surg. 1986; 204: 78-82.
32. Avgerinos A, Rekoumis G, Klonis C et al. Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomised controlled trial. J. Hepatol. 1993; 19: 301-11.
33. Özsoylu S, Koçak N, Yüce A. Propranolol for portal hypertension in children. J. Pediatr. 1985; 106: 317-20.
34. Jensen LS, Krarup N, Juhl CO, Nielsen TH, Larsen JA. Endoscopic, portographic, and hemodynamic evaluation of prolonged propranolol administration in pigs with experimental portal hypertension and oesophageal varices. Scand. J. Gastroenterol. 1989; 24: 213-22.
35. Donovan TJ, Ward M, Shepherd RW. Evaluation of endoscopic sclerotherapy of oesophageal varices in children. J. Pediatr. Gastroenterol. Nutr. 1986; 5: 696-700.
36. Westaby D, Melia WM, MacDougall BRD et al. Injection sclerotherapy for oesophageal varices. A randomised trial of different treatment schedules. Gut 1984; 25: 129-32.